Browsing "Anaesthesia and Intensive Care" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 276 to 295 of 351 < previous   next >
PreviewIssue DateTitleAuthor(s)
2011Speeding dantrolene preparation for treating malignant hyperthermiaKugler, Y.; Russell, W.
1995SPUMS policy on asthma and divingGorman, D. F.; Veale, A. G.
1997Stabilization and Transport of the Critically Ill [book review]Gilligan, John Eugene
2016Stopping vs. continuing aspirin before coronary artery surgeryMyles, P.; Smith, J.; Forbes, A.; Silbert, B.; Jayarajah, M.; Painter, T.; Cooper, D.; Marasco, S.; McNeil, J.; Bussières, J.; Wallace, S.
2014Stress ulceration: prevalence, pathology and association with adverse outcomesPlummer, M.; Blaser, A.; Deane, A.
2013Subjective and objective experience of painTan, S.; Cyna, A.
1995Success of Surf Life Saving resuscitations in Queensland 1972-1992Fenner, Peter J.; Harrison, S. L.; Williamson, John Aubrey Henry; Williamson, B.
2004Suggestion, hypnosis and hypnotherapy: a survey of use, knowledge and attitudes of anaesthetistsColdrey, J.; Cyna, A.
2007Synthesis and biological activity of allosteric modulators of GABA B receptors part 3.3-(2,6-bis-iso-propyl-4-hydroxyphenyl)propanolsKerr, D.; Khalafy, J.; Ong, J.; Prager, R.; Rimaz, M.
2006Synthesis and biological activity of allosteric modulators of GABA(B) receptors, Part 1. N-(phenylpropyl)-1-arylethylaminesKerr, D.; Ong, J.; Perkins, M.; Prager, R.; Puspawati, N.
2006Synthesis and biological activity of allosteric modulators of GABA(B) receptors, Part 2. 3-(2,6-bis-tert-butyl-4-hydroxyphenyl)propanolsKerr, D.; Khalafy, J.; Ong, J.; Perkins, M.; Prager, R.; Puspawati, N.; Rimaz, M.
1998Tachycardia alone fails to change the myocardial pharmacokinetics and dynamics of lidocaine, thiopental, and verapamil after intravenous bolus administration in sheepHuang, Y.; Zheng, D.; Upton, R.; Gray, E.; Grant, C.
2006Tackling the burden of injury in Australasia: developing a binational trauma registryDavey, T.; Pollard, C.; Aitken, L.; Fitzgerald, M.; Bellamy, N.; Cass, D.; Danne, P.; Griggs, W.; Cameron, P.; Atkinson, R.; Hamill, J.; Rao, S.; Richardson, D.; O'Connor, C.
2004Tailoring reveals information requirements: the case of anaesthesia alarmsWatson, M.; Sanderson, P.; Russell, W.
2006Techniques for preventing hypotension during spinal anaesthesia for caesarean sectionCyna, A.; Andrew, M.; Emmett, R.; Middleton, P.; Simmons, S.; Cyna, A.M.
1995The (S)-enantiomer of 2-hydroxysaclofen is the active GABAB receptor antagonist in central and peripheral preparationsKerr, D.; Ong, J.; Doolette, D.; Schafer, K.; Prager, R.
2005The acute disposition of (R)- and (S)-methadone in brain and lung of sheepFoster, D.; Upton, R.; Somogyi, A.; Grant, C.; Martinez, A.
2001The anti-nociceptive efficacy of low dose intramuscular xylazine in lambsGrant, C.; Upton, R.
1996The Australian Incident Monitoring Study in intensive care: AIMS-ICU. An analysis of the first year of reporting.Beckmann, U.; Baldwin, I.; Hart, G.; Runciman, W.
1996The Australian Incident Monitoring Study in Intensive Care: AIMS-ICU. The development and evaluation of an incident reporting system in intensive careBeckmann, U.; West, L.; Groombridge, G.; Baldwin, I.; Hart, G.; Clayton, D.; Webb, R.; Runciman, W.